Skip to main content
Daan Gene Co., Ltd. logo

Daan Gene Co., Ltd. — Investor Relations & Filings

Ticker · 002030 ISIN · CNE000001KP1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,189 across all filing types
Latest filing 2025-03-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002030

About Daan Gene Co., Ltd.

https://www.daangene.com

Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.

Recent filings

Filing Released Lang Actions
2024年度监事会工作报告
Board/Management Information Classification · 90% confidence The document is titled '2024 年度监事会工作报告' which translates to '2024 Supervisory Board Work Report'. It details the supervisory board's activities, meetings, oversight of financial conditions, internal controls, compliance with laws, and audit opinions for the year 2024. It includes references to quarterly and half-year reports but does not itself contain financial statements or detailed financial data. The document is a report on the supervisory board's work and oversight rather than a full annual report or audit report. It is not a short announcement or certification but a substantive report on governance and supervisory activities. This fits best under the category of Board/Management Information (MANG), as it relates to the supervisory board's oversight and governance activities rather than financial results or audit opinions alone.
2025-03-28 Chinese
2024年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It contains detailed audit opinions, audit basis, key audit matters, and responsibilities of management and auditors. It includes comprehensive financial statements such as balance sheets, income statements, cash flow statements, and notes to the financial statements for the fiscal year ending December 31, 2024. The content is consistent with a standalone audit report rather than a full annual report or other filing types. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the document fits the category of Audit Report / Information (AR). FY 2024
2025-03-28 Chinese
2024年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the 2024 profit distribution plan of Guangzhou Da An Gene Co., Ltd. It details the company's decision not to distribute cash dividends, not to issue bonus shares, and not to convert capital reserves into share capital for the year 2024. The document includes board and supervisory committee meeting resolutions, profit figures, and compliance with relevant regulations. It is a formal announcement of the dividend distribution plan rather than the dividend payment itself or a full financial report. The document length is 2748 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Notice of Dividend Amount (DIV).
2025-03-28 Chinese
2024年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2024 年度董事会工作报告' which translates to '2024 Annual Board of Directors Work Report'. It details the activities, meetings, and resolutions of the board of directors throughout the year 2024. It includes comprehensive information about the board's work, committee activities, company governance, operational and financial performance, and strategic initiatives. The document is lengthy (15,000 characters) and contains substantive content about the board's management and oversight functions rather than just announcements or summaries. It is not a full annual report (10-K) as it focuses specifically on the board's work and governance rather than full financial statements and company-wide annual disclosures. It is not a proxy statement, voting results, or other categories. The content aligns best with the category 'Board/Management Information (MANG)' which covers announcements and reports about changes or activities of the board and senior management. Therefore, the document should be classified as MANG with high confidence.
2025-03-28 Chinese
关于参股孙公司珠海雅莎生物科技股份有限公司拟申请公司股票在全国中小企业股份转让系统终止挂牌的公告
Delisting Announcement Classification · 95% confidence The document is an official announcement from Guangzhou Da An Gene Co., Ltd. regarding its subsidiary Zhuhai Yasha Biotechnology Co., Ltd.'s plan to apply for termination of stock listing on the National SME Share Transfer System. It includes detailed background information about the subsidiary, its shareholding structure, financial data, business independence, and the rationale and impact of the delisting. The document is a formal public notice about the delisting application and related corporate governance matters, not a financial report or audit. It does not contain financial statements or earnings data for the parent company, nor is it a transcript or presentation. The key phrase '拟申请公司股票在全国中小企业股份转让系统终止挂牌的公告' translates to 'Announcement on the application for termination of stock listing,' indicating this is a delisting announcement. Therefore, the appropriate classification is Delisting Announcement (DLST). The document length (7633 characters) and content support this classification with high confidence.
2025-03-28 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of Guangzhou Da An Gene Co., Ltd. It includes information about the meeting date, location, voting procedures (both in-person and online), agenda items to be voted on, and instructions for shareholders. The document does not contain financial statements or detailed financial performance data but rather focuses on the logistics and agenda of the upcoming AGM. This matches the definition of 'AGM Information' which includes presentations and materials shared during the AGM or notices about the AGM itself. The document length is over 6000 characters, indicating it is a full notice rather than a brief announcement. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-03-28 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.